|
IMPCL achieves highest-ever turnover of over Rs. 160 crore
|
|
Our Bureau, Mumbai
April 16 , 2021
|
|
|
The Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Union Ministry of Ayush has recorded a turnover of Rs. 164.33 crore for the financial year 2020-21.
The company has recorded an all-time high profit of approximately Rs. 12 crore. Its previous highest turnover was Rs. 97 crore in 2019-20, said the Ayush ministry.
Adding another feather in IMPCL’s cap, the Central Drugs Standards Control Organisation (CDSCO) recently recommended its 18 ayurvedic products for World Health Organization, Good Manufacturing Practices/Certificate of Pharmaceutical Product (WHO-GMP/COPP) certification subject to certain observations in March 2021.
The WHO provides World Health Organization, Good Manufacturing Practices/Certificate of Pharmaceutical Product certification to companies after conducting an inspection. This certification is an endorsement of the quality of IMPCL’s products. It will help IMPCL to commence export operation of quality medicines at a global level.
During the Covid-19 pandemic, it was able to cater to the needs of the country in the shortest time, probably the first company in the country to provide immuno boosting medicines such as AurakshaImmuno Boosting Kit at Rs. 350. It is one of the lowest-priced such kits and is also available on Amazon. Nearly 2 lakh such kits have been sold in the last two months, said the statement issued by the Ayush ministry.
Presently, IMPCL is manufacturing 656 classical ayurvedic, 332 Unani and 71 proprietary ayurvedic medicines for the various diseases spectrum. It has contributed towards research and development activities and 25 new proprietary ayurvedic medicines as per the Essential Drug List (EDL), it further stated.
IMPCL is one of the most trusted manufacturers of Ayush medicines in the country and is known for the authenticity of its formulations.
Every government institution doing business with IMPCL has praised the company for providing steady support to various health programmes and ensuring an unbroken supply of products during the Covid-19 pandemic.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|